Coherus Oncology, Inc. (CHRS)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Coherus Oncology, Inc. reported revenue of $42.17M, up 59.8% from the prior year. The company was profitable, with a net margin of 398.4%. It held $258.34M in total assets against $197.33M in total liabilities.
Key ratios (FY2025)
-429.5%
Operating margin
398.4%
Net margin
275.4%
Return on equity
+59.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.17M | $26.39M | $257.24M | $211.04M | $326.55M | $475.82M | $356.07M | $0 | $1.56M | $189.48M |
| Cost of Revenue | $13.81M | $8.73M | $158.99M | $70.08M | $57.59M | $37.67M | $17.08M | — | — | — |
| Operating Income | -$181.13M | -$199.65M | -$203.20M | -$256.88M | -$263.86M | $156.32M | $107.77M | -$204.42M | -$232.14M | -$115.93M |
| Net Income | $168.02M | $28.51M | -$237.89M | -$291.75M | -$287.10M | $132.24M | $89.83M | -$209.34M | -$238.17M | -$127.34M |
| EPS (Diluted) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.62 | $1.23 | $-3.22 | $-4.48 | — |
| Total Assets | $258.34M | $448.53M | $629.60M | $480.85M | $679.33M | $841.65M | $408.93M | $99.47M | $162.61M | $178.49M |
| Total Liabilities | $197.33M | $580.52M | $823.03M | $618.26M | $581.61M | $560.67M | $303.71M | $138.06M | $132.08M | $159.13M |
| Shareholders' Equity | $61.01M | -$131.99M | -$193.43M | -$137.42M | $97.73M | $280.97M | $105.21M | -$38.59M | $30.54M | $20.53M |
| Cash & Equivalents | $88.88M | $125.99M | $102.89M | $63.55M | $417.19M | $541.16M | $177.67M | $72.36M | $126.91M | $124.95M |
| Operating Cash Flow | -$138.51M | -$20.44M | -$174.88M | -$241.12M | -$37.43M | $154.15M | $28.36M | -$159.27M | -$200.29M | -$252.54M |
| Capital Expenditures | — | — | $286.0K | $2.04M | $1.29M | $7.23M | $1.82M | $789.0K | $4.57M | $6.51M |
| Shares Outstanding | 121.15M | 115.61M | 112.22M | 78.85M | 76.93M | 72.51M | 70.37M | 68.30M | 59.84M | 45.81M |